Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-005717-19Phase 4Terminated
Phase 4 trial of hydrochlorothiazide, sponsored by Oulu University Hospital. Primary endpoint: Change in serum potassium concentration. Started Oct 2007; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-005717-19.